Brief: Crescita says topical anesthetic Pliaglis wins Mexico approval
09/09/2016 12:30
Sept 9 (Reuters) - Crescita Therapeutics Inc CTX.TO
* Crescita therapeutics announces approval of Pliaglis in
mexico
* Company is transitioning these rights from Galderma and
expects this process to be completed early in q4
* Says company will be seeking a licensing partner for
pliaglis in mexico
Source text for Eikon: ID:nCNWSR380a
Further company coverage: CTX.TO
((Bangalore.newsroom@thomsonreuters.com ;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium